Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Disease

  2.3.2 Market Size By Test Type

  2.3.3 Market Size By End-Use

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Disease-specific diagnostic performance metrics

4.1.1 Share (%) of demand by disease (bacterial enteric disease, viral enteric disease, parasitic enteric disease).

4.1.2 Improvement (%) in disease detection accuracy, pathogen identification, and outbreak surveillance capabilities.

4.1.3 Reduction (%) in misdiagnosis rates, delayed diagnoses, and disease transmission risks.

4.2 Testing technology performance & laboratory efficiency metrics

4.2.1 Share (%) of demand by test type (immunoassay, molecular, conventional, chromatography & spectrometry, other test types).

4.2.2 Improvement (%) in diagnostic sensitivity, specificity, turnaround time, and laboratory productivity.

4.2.3 Reduction (%) in false-positive results, false-negative results, and repeat testing requirements.

4.3 End-user performance & healthcare delivery metrics

4.3.1 Share (%) of demand by end-use (hospitals, diagnostic laboratories, research & academic institutes, other end-users).

4.3.2 Improvement (%) in testing capacity, clinical decision-making, and patient management efficiency.

4.3.3 Reduction (%) in reporting delays, laboratory workflow bottlenecks, and operational inefficiencies.

4.4 Infectious disease surveillance & public health metrics

4.4.1 Improvement (%) in outbreak monitoring, epidemiological tracking, and public health response effectiveness.

4.4.2 Reduction (%) in community transmission rates, healthcare burden, and undetected infection cases.

4.4.3 Growth (%) in adoption driven by increasing incidence of gastrointestinal infections, expanding disease surveillance programs, and growing awareness regarding early pathogen detection.

5. Enteric Disease Testing Market Segmental Analysis & Forecast, By Disease, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Bacterial Enteric Disease

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

 5.3 Viral Enteric Disease

 5.4 Parasitic Enteric Disease

6. Enteric Disease Testing Market Segmental Analysis & Forecast, By Test Type, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Immunoassay

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

 6.3 Molecular

 6.4 Conventional

 6.5 Chromatography & Spectrometry

 6.6 Other Test Types

7. Enteric Disease Testing Market Segmental Analysis & Forecast, By End-Use, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Hospitals

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

 7.3 Diagnostic Laboratories

    7.4 Research & Academic Institutes

    7.5 Other End-Users

8. Enteric Disease Testing Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Enteric Disease Testing Market Size & Forecast, By Disease, 2022–2035

 8.2.3 Enteric Disease Testing Market Size & Forecast, By Test Type, 2022–2035

 8.2.4 Enteric Disease Testing Market Size & Forecast, By End-Use, 2022–2035

 8.2.5 Enteric Disease Testing Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Enteric Disease Testing Market Size & Forecast, By Disease, 2022–2035

 8.3.3 Enteric Disease Testing Market Size & Forecast, By Test Type, 2022–2035

 8.3.4 Enteric Disease Testing Market Size & Forecast, By End-Use, 2022–2035

 8.3.5 Enteric Disease Testing Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Enteric Disease Testing Market Size & Forecast, By Disease, 2022–2035

 8.4.3 Enteric Disease Testing Market Size & Forecast, By Test Type, 2022–2035

 8.4.4 Enteric Disease Testing Market Size & Forecast, By End-Use, 2022–2035

 8.4.5 Enteric Disease Testing Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Enteric Disease Testing Market Size & Forecast, By Disease, 2022–2035

 8.5.3 Enteric Disease Testing Market Size & Forecast, By Test Type, 2022–2035

 8.5.4 Enteric Disease Testing Market Size & Forecast, By End-Use, 2022–2035

 8.5.5 Enteric Disease Testing Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Enteric Disease Testing Market Size & Forecast, By Disease, 2022–2035

 8.6.3 Enteric Disease Testing Market Size & Forecast, By Test Type, 2022–2035

 8.6.4 Enteric Disease Testing Market Size & Forecast, By End-Use, 2022–2035

 8.6.5 Enteric Disease Testing Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 Egypt

  8.6.5.5 South Africa

  8.6.5.6 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022–2025

  9.2.3 Number Of Strategies Adopted By Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features By Key Players

  9.4.2 Product/Service Heatmap By Key Players

  9.4.3 Application Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

9.6.1 bioMérieux SA.

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Product/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

9.6.2 Cepheid (Danaher Corporation)

9.6.3 Thermo Fisher Scientific Inc.

9.6.4 Abbott Laboratories

9.6.5 Roche Diagnostics GmbH

9.6.6 Meridian Bioscience Inc.

9.6.7 Luminex Corporation (DiaSorin)

9.6.8 BD (Becton, Dickinson and Company)

9.6.9 Quidel Corporation (QuidelOrtho)

9.6.10 Hologic Inc.

9.6.11 Seegene Inc.

9.6.12 Qiagen NV

9.6.13 Siemens Healthineers AG

9.6.14 Bio-Rad Laboratories Inc.

9.6.15 Danaher Corporation

9.6.16 Chembio Diagnostics Inc.

9.6.17 Coris BioConcept SPRL

9.6.18 BÜHLMANN Laboratories AG

9.6.19 Savyon Diagnostics Ltd.

9.6.20 CorisBioConcept SA

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions On Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures